News

Dr Farah Patell-Socha and Furqan Iqbal interviewed in the latest issue of Technology Networks.

VP of Research Products Dr Farah Patell-Socha discusses more accurate cell models in neurodegeneration.

CEO Mark Kotter gives an evening lecture at the famous Royal Institution on the cell reprogramming revolution.

bit.bio expands senior team with four female hires in further preparation for cell therapies.

The award was presented at evening ceremony in central London.

The posters demonstrate the capability of opti-ox technology to create any human cell.

bit.bio and Charles River Laboratories discuss the potential of precision reprogrammed human cells.

The piece talks about how bit.bio has "cracked the code" to grow human cells for a new era of regenerative medicine.